RxDoctor Payments Data

John Anderson, MD

Foot and Ankle Surgery · Grand Rapids, MINPI 1700874294

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,019,561 of the $1,277,957 with a category attached, or 79.8%. 20 manufacturers reported payments, led by Stryker at 42.0% of the total. Reporting peaked in 2022 at $334,316 and has fallen 69.3% since, to $102,585 in 2025. Among foot and ankle surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,277,957in general payments, 2019–2025

Across 358 payments — averaging $3569.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$537K
  • Medartis Inc.$396K
  • Paragon 28, Inc.$147K
  • Nextremity Solutions Inc.$98K
  • Zimmer Biomet$67K
  • Johnson & Johnson$15K
  • plus $18K from 14 others
$52,766in research payments, 2019–2025

Across 18 payments — averaging $2931.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$29K
  • Zimmer Biomet$14K
  • Paragon 28, Inc.$10K

What the payments were for

  • Royalty or licence$1,019,56180%
  • Consulting fees$222,20017%
  • Speaking & faculty fees$2500%
  • Travel & lodging$21,8762%
  • Food & beverage$10,0271%
  • Education$4,0360%
  • Gifts$60%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,277,957 in reported general payments places this provider in the 95th percentile of 384 foot and ankle surgery providers in Michigan.

See all foot and ankle surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$100,135
Medicare patients
204
Services billed
2,158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen132$785
Cyclobenzaprine Hcl136$431
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$361
Cephalexin31$195
Gabapentin12$143
Celecoxib13$132
Tramadol Hcl15$40
Amoxicillin29$26

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →